Monitoring pain levels using electrodermal activity
Detection of Electrodermal Activity in Pain (DEEP)
Copenhagen University Hospital, Hvidovre · NCT06677593
This study is testing if a device that measures skin activity can help understand pain levels in cancer and COPD patients by comparing their reports of pain with the device's readings.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 37 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Copenhagen University Hospital, Hvidovre (other) |
| Locations | 1 site (Hvidovre) |
| Trial ID | NCT06677593 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the relationship between self-reported pain levels and electrodermal activity in patients suffering from cancer and chronic obstructive pulmonary disease (COPD). A total of 37 patients will wear a monitoring device for up to one week, during which they will report their pain intensity multiple times a day. The study will utilize discriminant analysis to differentiate between varying levels of pain intensity, generating hypotheses for future research phases. The ultimate goal is to develop an algorithm that can detect pain and provide timely alerts for patients experiencing persistent pain.
Who should consider this trial
Good fit: Ideal candidates are Danish adults over 18 years old with persistent or recurrent pain due to cancer or COPD.
Not a fit: Patients with current psychological disorders, impaired cognitive function, or substance abuse issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management and timely interventions for patients with life-threatening illnesses.
How similar studies have performed: While this approach is exploratory, similar studies have shown promise in using electrodermal activity for pain detection, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Danish * Age over 18 * Persistent or recurrent pain (longer than three months) * Cancer: DC01-DC9 or Pulmonary Diseases:DJ40-DJ47 Exclusion Criteria: * A current diagnosis with psychological/ psychiatric disorders * Impaired cognitive function * Substance abuse * A skin condition on the to-be-tested body parts * PHQ-9 reveals suicidal ideation
Where this trial is running
Hvidovre
- Copenhagen University Hospital - Hvidovre — Hvidovre, Denmark (RECRUITING)
Study contacts
- Principal investigator: Kirstine S Benthien, PhD — University of Copenhagen
- Study coordinator: Kirstine S Benthien, PhD
- Email: kirstine.skov.benthien.01@regionh.dk
- Phone: +45 21 59 65 92
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer, Chronic Obstructive Pulmonary Disease (COPD, Pain, pain, electrodermal activity, pain detection, pain prediction, galvanic skin response